Steroid therapy in progressive IgA nephropathy: A 10 year follow-up study

Nephrology

Volumn 3, Issue SUPPL. 2, 1997, Pages s739-s745

  Kobayashi, Yutaka ^a   Hiki, Yoshiyuki ^a   Kokubo, Tohru ^a   Sano, Takashi ^a   Hashixume, Kenjiro ^a   Tateno, Sumio ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Corticosteroids; Massive proteinuria; Preserved renal function; Steroid therapy

Indexed keywords

ANTITHROMBOCYTIC AGENT; STEROID;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HISTOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; STEROID THERAPY; TREATMENT OUTCOME;

EID: 0030720992     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.1997.tb00294.x     Document Type: Conference Paper

References (24)

1. Berger J, Hinglais N. Les depots intercapillaires d'IgA-IgG. J. Urol. Nephrol. 1968; 74:694-5.
2. Schena P. A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am. J.Med. 1990; 89: 209-15.
3. D'Amico G. Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membrano-proliferative glomerulonephritis: Survey of the recent literature. Am. J. Kidney Dis. 1992; 20:315-23.
4. Ibels LS, Gyory AZ. IgA nephropathy: Analysis of thenatural history, important factors in the progression of renal disease, and a review of the literature. Medicine 1994; 73: 79-102.
5. Kobayashi Y, Tateno S, Hiki Y, Shigematsu H. IgAnephropathy: Prognostic significance of proteinuria and histological alterations. Nephron 1983; 34:146-53.
6. Kobayashi Y, Hiki Y, Fujii K, Kurokawa A, Tateno S. Moderately proteinuric IgA nephropathy: Prognostic prediction of individual clinical courses and steroid therapy in progressive cases. Nephron. 1989; 53: 250-6.
7. Kobayashi Y, Kokubo T, Horii A, Hiki Y, Tateno S. Prognostic prediction of long-term clinical courses in individual IgA nephropathy patients. Nephrology 1997; 3:35-40.
8. D'Amico G. Epidemiology, clinical and prognostic indices in IgA nephropathy. Nephrology 1997;3: 13-17.
9. Clarkson AR, Woodroffe AJ, Bannister KM, Odum J, Thomas A. Therapy in IgA nephropathy, In: Bene MC, Faurc G, Kessler M (eds), IgA nephropathy: The 25th year. Contrib.Nephrol. Basel, Karger, 1993; 104:189-97.
10. Julian BA, van den Wall Bake AWL. Treatment options in IgA nephropathy. Nephrology 1997; 3: 103-8.
11. Kobayashi Y, Fujii K, Hiki Y, Tateno S. Steroid therapy in IgA nephropathy: A prospective pilot study in moderate proteinuric cases. Quart. J. Med. 1986; 61:935-43.
12. Kobayashi Y, Hiki Y, Fujii K, Kurokawa A, Kamiyama M, Tateno S. IgA nephropathy: Heterogeneous clinical pictures and steroid therapy in progressive cases. Semin. Nephrol. 1987; 7: 382-5.
13. Kobayashi Y, Fujii K, Hiki Y, Tateno S, Kurokawa A, Kamiyama M. Steroid therapy in IgA nephropathy: A retrospective study in heavy proteinuric cases. Nephron 1988; 48: 12-17.
14. Kobayashi Y, Hiki Y, Kokubo T, Horii A, Tateno S. Steroid therapy during the early stage of progressive IgA nephropathy: 10-year follow-up study. Nephron 1996; 72: 237-42.
15. Clarkson AR, Seymour AE, Woodroffe AJ, McKenzie PE, Chan Y-I, Wootton AM. Controlled trial of phenytoin therapy in IgA nephropathy. Clin. Nephrol. 1980; 13: 215-8.
16. Mustonen J, Pasternack A, Rantala I. The nephrotic syndrome in IgA glomerulonephritis. Response to corticosteroid therapy. Clin. Nephrol. 1983; 20: 172-6.
17. Lai KN, Lai FM, Ho CP, Chan KW. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome. A long-term controlled trial. Clin. Nephrol. 1986; 26: 174-80.
18. Waldo FB, Alexander R, Wyatt RJ, Kohaut EC. Alternate-day prednisone therapy in children with IgA-associated nephritis. Am. J. Kidney Dis. 1989; 13: 55-60.
19. Andreoli SP, Bergstein JM. Treatment of severe IgA nephropathy in children. Pediatr. Nephrol. 1989; 13: 248-53.
20. Welch TR, Fryer C, Shely E, Witte DP, Quinlan M. Double-blilnd, controlled trial of short-term prednisone therapy in immunoglobulin A glomerulonephritis. J. Pediatr. 1992; 121: 474-7.
21. Waldo FB, Wyatt RJ, Kelly DR et al. Treatment of IgA nephropathy in children: Efficacy of alternate-day oral prednisone. Pediatr. Nephrol. 1993; 7: 579-32.
22. Julian BA, Barker C. Alternate-day prednisone therapy in IgA nephropathy: Preliminary analysis of a prospective, randomized, controlled trial. In: Bene MC, Faure G, Kessler M (eds): IgA nephropathy: The 25th year. Contrib. Nephrol, Basel, Karger, 1993; 104: 198-206.
23. Roccatello D, Ferro M, Coppo R et al. Treatment of rapidly progressive IgA nephropathy. In: Clarkson AR, Woodroffe AJ (eds): IgA nephropathy: Pathogenesis and treatment. Contrib. Nephrol. Basel, Karger, 1995; 111: 177-83.
24. Goumenos D, Ahuja M, Shortland JR, Brown CB. Can immunosuppressive drugs slow the progression of IgA nephropathy? Nephrol. Dial. Transplant. 1995; 10: 1173-81.